Innovative preclinical research in 2025 on C9orf72 mutation-associated frontotemporal dementia (FTD) demonstrated that increasing brain omega-3 content extended survival in model organisms and patient-derived cells [34]. The gene discussed is C9orf72; the disease is frontotemporal dementia.